Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Hidradenitis suppurativa

Hidradenitis suppurativa

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Hidradenitis suppurativa

38 trials tracked for Hidradenitis suppurativa: 7 in phase 3 or 4 and 4 with published results. The most-cited published study has 298 citations.

38Trials tracked
7Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 7 Phase 2 23 Other / NA 8
  1. Phase 3 Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) Completed · 298 cited
  2. Phase 3 This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). Completed · 296 cited
  3. Phase 3 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Completed · 6 cited
  4. Phase 3 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Completed · 5 cited
  5. Phase 3 Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa Completed
  6. Phase 3 Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Completed
Show 32 more trials
  1. Phase 3 Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa Completed
  2. Phase 2 Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa Completed
  3. Phase 2 A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Completed
  4. Phase 2 A Study of LY3041658 in Adults With Hidradenitis Suppurativa Completed
  5. Phase 2 A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa Completed
  6. Phase 2 Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa Completed
  7. Phase 2 A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Completed
  8. Phase 2 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa Completed
  9. Phase 2 Tofacitinib for Immune Skin Conditions in Down Syndrome Completed
  10. Phase 2 A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa Completed
  11. Phase 2 Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Completed
  12. Phase 2 A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Completed
  13. Phase 2 To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa Completed
  14. Phase 2 Hidradenitis Suppurativa Phase 2b Study of Izokibep Completed
  15. Phase 2 ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Completed
  16. Phase 2 A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Completed
  17. Phase 2 A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Completed
  18. Phase 2 A Study of Bermekimab in Patients With Hidradenitis Suppurativa Completed
  19. Phase 2 Etanercept for Treatment of Hidradenitis Completed
  20. Phase 2 Anakinra as a Treatment for Hydradenitis Suppurativa Completed
  21. Phase 2 Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Completed
  22. Phase 2 A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial Completed
  23. Phase 2 A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa Completed
  24. Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa Completed
  25. N/A Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients Completed
  26. N/A HidraWear Study for Hidradenitis Suppurativa Wounds Completed
  27. N/A Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa Completed
  28. N/A Wound Dressings for Hidradenitis Suppurativa Completed
  29. N/A A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa. Completed
  30. N/A Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery Completed
  31. N/A Hidradenitis Suppurativa (HS) Tunneling Wounds Completed
  32. N/A A Bioelectric Dressing for Post De-Roofing Treatment of HS Completed

Showing the 38 most-cited and recently-updated of 38 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Narrative review links hidradenitis suppurativa to metabolic dysfunction and systemic inflammation
Gastroenterology Sys. Review
Narrative review links hidradenitis suppurativa to metabolic dysfunction and systemic inflammation New review links skin disease to metabolic health in Hidradenitis suppurativa
This narrative review examines the association between hidradenitis suppurativa and metabolic syndrome. The authors argue that increasing ev…
A new review suggests Hidradenitis suppurativa is part of a broader inflammatory state tied to metabolic dysfunction, urging a multidiscipli…
Frontiers May 26, 2026
Systematic review shows regional differences in HS comorbidity prevalence across North America, Europe, and Asia
Dermatology Meta-analysis
Systematic review shows regional differences in HS comorbidity prevalence across North America, Europe, and Asia Regional differences in health risks for hidradenitis suppurativa patients
This systematic review and meta-analysis examines the prevalence of hidradenitis suppurativa-associated comorbidities across North America, …
A meta-analysis reveals how hidradenitis suppurativa patients in North America, Europe, and the Middle East/Asia face different odds for dia…
May 1, 2026
Review of anti-TL1A therapies for hidradenitis suppurativa with no reported outcomes or safety data
Cardiology Sys. Review
Review of anti-TL1A therapies for hidradenitis suppurativa with no reported outcomes or safety data New review looks at anti-TL1A therapies for hidradenitis suppurativa
This narrative review discusses anti-TL1A therapies, specifically tulisokibart, for hidradenitis suppurativa.
A new review explores anti-TL1A therapies for hidradenitis suppurativa, offering fresh insights into treating this painful skin condition.
Frontiers Apr 23, 2026
FDA Approves Cosentyx (secukinumab) for Moderate to Severe Hidradenitis Suppurativa in Adults and Pediatric Patients
Dermatology FDA Approval
FDA Approves Cosentyx (secukinumab) for Moderate to Severe Hidradenitis Suppurativa in Adults and Pediatric Patients The FDA approved a new use for the drug Cosentyx to treat a painful skin condition
The FDA has approved Cosentyx for moderate to severe hidradenitis suppurativa in adults and pediatric patients 12 years and older.
The FDA has approved Cosentyx for treating moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps.
FDA Apr 22, 2026